Sphingosine-1-Phosphate (S1P) and S1P Signaling Pathway Modulators, from Current Insights to Future Perspectives
Sphingosine-1-phosphate (S1P) and S1P receptors (S1PR) are bioactive lipid molecules that are ubiquitously expressed in the human body and play an important role in the immune system. S1P-S1PR signaling has been well characterized in immune trafficking and activation in both innate and adaptive immu...
Main Authors: | Gary Álvarez Bravo, René Robles Cedeño, Marc Puig Casadevall, Lluís Ramió-Torrentà |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-06-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/11/13/2058 |
Similar Items
-
Current Status of Oral Disease-Modifying Treatment Effects on Cognitive Outcomes in Multiple Sclerosis: A Scoping Review
by: Vincenzo Carlomagno, et al.
Published: (2023-07-01) -
Single-Nucleus RNA-seq of Normal-Appearing Brain Regions in Relapsing-Remitting vs. Secondary Progressive Multiple Sclerosis: Implications for the Efficacy of Fingolimod
by: Yasuyuki Kihara, et al.
Published: (2022-06-01) -
Bioavailable central nervous system disease-modifying therapies for multiple sclerosis
by: Hans-Peter Hartung, et al.
Published: (2023-11-01) -
The Selective Agonist for Sphingosine-1-Phosphate Receptors Siponimod Increases the Expression Level of <i>NR4A</i> Genes in Microglia Cell Line
by: Francesca Montarolo, et al.
Published: (2022-03-01) -
Central Versus Peripheral Drug Exposure Ratio, a Key Differentiator for Siponimod Over Fingolimod?
by: Marc Bigaud, et al.
Published: (2023-05-01)